In order to determine if the CCI-induced increase in the expression of IL-1β at day 1 post-surgery modulates the development of MA, we examined the effect of administration of the IL-1 receptor antagonist (IL-1ra; 6, 20, or 60 ng) on the development of MA. The gene discussed is IL1B; the disease is microtia.